Prelude Therapeutics Inc (PRLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Operating Expenses | 58,763 | 28,109 | 0 | 0 | 0 |
| Operating Income | -58,763 | -28,109 | N/A | N/A | N/A |
| Other Income | 1,834 | 539 | 0 | 0 | 0 |
| Pre-tax Income | -56,929 | -27,570 | 0 | 0 | 0 |
| Net Income Continuous | -56,929 | -27,570 | N/A | N/A | N/A |
| Net Income | $-56,929 | $-27,570 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -4.56 | -16.52 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -4.56 | -16.52 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -4.56 | -16.52 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -4.56 | -16.52 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -4.56 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-58,221 | $-27,727 | $N/A | $N/A | $N/A |